{"total":62,"page":1,"pageSize":25,"pages":3,"millis":13,"query":{"q":"health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","kind":"","level":"","type":"","quarter":"2021Q1","grade":"","collection":"","from":"","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-002","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19, 85 Fed. Reg. 19392 (Apr. 7, 2020)","title":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19","dateIssued":"2020-04-02","startDate":"2020-04-02","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-002","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-002"},{"id":"AGY-FED-HEALTH-OTHER-021","kind":"context","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213)","instrument":"DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider\u0027s DEA-registered location during the COVID-19 public health emergency","title":"Administering Certain CS in the parking lot of a healthcare provider\u0027s DEA-registered location during the COVID-19 public health emergency","dateIssued":"2020-07-28","startDate":"2020-07-28","endDate":"2021-09-30","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-021","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-021"},{"id":"AGY-FED-HEALTH-OTHER-001","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 22024 (Apr. 21, 2020)","title":"Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-03-17","startDate":"2020-03-17","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-001","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-001"},{"id":"AGY-FED-HEALTH-OTHER-043","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020)","title":"Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency","dateIssued":"2020-03-22","startDate":"2020-03-22","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-043","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-043"},{"id":"AGY-FED-HEALTH-OTHER-003","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020)","title":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-04-09","startDate":"2020-04-09","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-003","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-003"},{"id":"AGY-FED-HEALTH-OTHER-038","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Determination of Public Health Emergency and Declaration that circumstances exist justifying emergency use of in vitro diagnostics, 85 Fed. Reg. 7316 (Feb. 7, 2020)","title":"Determination of Public Health Emergency","dateIssued":"2020-02-04","startDate":"2020-02-04","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["EMER","SUPPLY"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-038","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-038"},{"id":"AGY-FED-HEALTH-OTHER-044","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023)","title":"Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"2023-09-05","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","MASK","OTHER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-044","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-044"},{"id":"AGY-FED-HEALTH-OTHER-061","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs (Robert L. Wilkie, Secretary)","instrument":"Interim Final Rule, Authority of VA Professionals To Practice Health Care, 85 Fed. Reg. 71838 (Nov. 12, 2020)","title":"Authority of VA Professionals To Practice Health Care","dateIssued":"2020-11-12","startDate":"2020-11-12","endDate":"2021-09-30","quarters":["2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-061","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-061"},{"id":"AGY-FED-HEALTH-OTHER-005","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Robinsue Frohboese, Acting Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for the Scheduling of Individual Appointments for COVID-19 Vaccination During the COVID-19 Nationwide Public Health Emergency, 86 Fed. Reg. 11076 (Feb. 24, 2021)","title":"Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for the Scheduling of Individual Appointments for COVID-19 Vaccination","dateIssued":"2021-01-19","startDate":"2020-12-11","endDate":"2023-05-11","quarters":["2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-005","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-005"},{"id":"AGY-FED-HEALTH-OTHER-015","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division","instrument":"DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)","title":"How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency","dateIssued":"2020-03-31","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-015","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-015"},{"id":"AGY-FED-HEALTH-OTHER-027","kind":"context","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA","instrument":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","title":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-027","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-027"},{"id":"AGY-FED-HEALTH-OTHER-041","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 19, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-041","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-041"},{"id":"AGY-FED-HEALTH-OTHER-042","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-042","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-042"},{"id":"AGY-FED-HEALTH-OTHER-046","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency (Apr. 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency","dateIssued":"2020-04-01","startDate":"2020-04-01","endDate":"2023-11-07","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-046","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-046"},{"id":"AGY-FED-HEALTH-OTHER-118","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Secretary of Health and Human Services (terms administered by HRSA)","instrument":"Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General Distribution","title":"Acceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-118","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-118"},{"id":"AGY-FED-HEALTH-OTHER-045","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency (Mar. 26, 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency","dateIssued":"2020-03-26","startDate":"2020-03-26","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-045","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-045"},{"id":"AGY-FED-HEALTH-OTHER-032","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under CLIA Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance, 85 Fed. Reg. 13138 (Mar. 6, 2020)","title":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under the Clinical Laboratory Improvement Amendments Prior to Emergency Use Authorization for Coronavirus Disease-2019","dateIssued":"2020-02-29","startDate":"2020-02-29","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-032","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-032"},{"id":"AGY-FED-HEALTH-OTHER-052","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Jacqueline A. O\u0027Shaughnessy, Acting Chief Scientist, FDA (letter to CDC)","instrument":"Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021)","title":"Letter of Authorization to CDC, NIOSH-Approved Air Purifying Respirators (reissued July 12, 2021)","dateIssued":"2021-07-12","startDate":"2020-03-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-052","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-052"},{"id":"AGY-FED-HEALTH-OTHER-040","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020)","title":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19","dateIssued":"2020-03-10","startDate":"2020-02-04","endDate":"2020-10-20","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","EMER","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-040","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-040"},{"id":"AGY-FED-HEALTH-OTHER-025","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies","instrument":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","title":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","dateIssued":"2020-04-21","startDate":"2020-04-21","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-025","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-025"},{"id":"AGY-FED-HEALTH-OTHER-026","kind":"order","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA (Assistant Secretary for Mental Health and Substance Use)","instrument":"Opioid Treatment Program (OTP) Guidance (Mar. 16, 2020; updated Mar. 19, 2020): blanket take-home exceptions","title":"Opioid Treatment Program (OTP) Guidance","dateIssued":"2020-03-16","startDate":"2020-03-16","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-026","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-026"},{"id":"AGY-FED-HEALTH-OTHER-036","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Authorization Declaration (medical devices, including alternative products used as medical devices), 85 Fed. Reg. 17335 (Mar. 27, 2020)","title":"Emergency Use Authorization Declaration","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-036","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-036"},{"id":"AGY-FED-HEALTH-OTHER-037","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Authorization Declaration (drugs and biological products), 85 Fed. Reg. 18250 (Apr. 1, 2020)","title":"Emergency Use Authorization Declaration","dateIssued":"2020-03-27","startDate":"2020-03-27","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-037","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-037"},{"id":"AGY-FED-HEALTH-OTHER-039","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Declaration (personal respiratory protective devices), 85 Fed. Reg. 13907 (Mar. 10, 2020)","title":"Emergency Use Declaration","dateIssued":"2020-03-02","startDate":"2020-03-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-039","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-039"},{"id":"AGY-FED-HEALTH-OTHER-033","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020)","title":"Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability","dateIssued":"2020-05-12","startDate":"2020-05-12","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-033","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-033"}],"facets":{"kind":[{"value":"order","label":"Order","count":49},{"value":"context","label":"Context (guidance or announcement)","count":13}],"level":[{"value":"federal","label":"Federal","count":62}],"state":[],"type":[{"value":"OTHER","label":"Other","count":42},{"value":"HC","label":"Health care orders","count":37},{"value":"SUPPLY","label":"Supply chain","count":21},{"value":"TELE","label":"Telework mandate","count":11},{"value":"EMER","label":"Emergency declaration","count":6},{"value":"GATH","label":"Gathering cap","count":3},{"value":"CLOSE","label":"Business closure","count":2},{"value":"CRT","label":"Courts and public offices","count":2},{"value":"EMP","label":"Workplace rules","count":2},{"value":"MASK","label":"Face-covering requirement","count":2},{"value":"QUAR","label":"Quarantine and isolation","count":2},{"value":"SCH","label":"Schools and child care","count":2},{"value":"TRAV","label":"Travel and quarantine","count":2},{"value":"CAP","label":"Capacity limit","count":1}],"quarter":[{"value":"2021Q1","label":"2021 Q1","count":62},{"value":"2020Q4","label":"2020 Q4","count":60},{"value":"2021Q2","label":"2021 Q2","count":60},{"value":"2021Q3","label":"2021 Q3","count":59},{"value":"2020Q3","label":"2020 Q3","count":55},{"value":"2020Q2","label":"2020 Q2","count":52}],"grade":[{"value":"primary","label":"Primary source read","count":61},{"value":"secondary","label":"Confirmed from a secondary source","count":1}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":62}]}}